Dillon & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
26,489
-2,167
-8% -$193K 0.31% 43
2025
Q4
$2.26M Sell
28,656
-461
-2% -$36.1K 0.29% 42
2025
Q3
$2.33M Sell
29,117
-1,200
-4% -$102K 0.3% 42
2025
Q2
$2.76M Sell
30,317
-50
-0.2% -$4.57K 0.37% 41
2025
Q1
$2.85M Sell
30,367
-737
-2% -$66K 0.42% 41
2024
Q4
$2.83M Buy
31,104
+150
+0.5% +$14.3K 0.39% 41
2024
Q3
$3.22M Sell
30,954
-625
-2% -$63.7K 0.45% 38
2024
Q2
$3.06M Sell
31,579
-5,340
-14% -$493K 0.45% 40
2024
Q1
$3.32M Sell
36,919
-2,110
-5% -$179K 0.52% 37
2023
Q4
$3.12M Sell
39,029
-5,947
-13% -$447K 0.57% 39
2023
Q3
$3.19M Sell
44,976
-646
-1% -$48.3K 0.61% 37
2023
Q2
$3.51M Sell
45,622
-4,000
-8% -$310K 0.65% 37
2023
Q1
$3.72M Sell
49,622
-1,910
-4% -$142K 0.74% 33
2022
Q4
$4.07M Sell
51,532
-187
-0.4% -$14K 0.88% 29
2022
Q3
$3.62M Sell
51,719
-300
-0.6% -$23.5K 0.84% 30
2022
Q2
$4.16M Sell
52,019
-750
-1% -$58.6K 0.94% 31
2022
Q1
$4.01M Sell
52,769
-4,052
-7% -$321K 0.76% 31
2021
Q4
$4.83M Sell
56,821
-1,134
-2% -$88.6K 0.84% 32
2021
Q3
$4.41M Sell
57,955
-1,280
-2% -$102K 0.84% 31
2021
Q2
$4.8M Sell
59,235
-13,378
-18% -$1.09M 0.94% 30
2021
Q1
$5.74M Sell
72,613
-6,080
-8% -$477K 1.23% 28
2020
Q4
$6.77M Sell
78,693
-4,222
-5% -$349K 1.47% 24
2020
Q3
$6.38M Sell
82,915
-2,880
-3% -$220K 1.54% 25
2020
Q2
$6.26M Sell
85,795
-2,835
-3% -$201K 1.7% 24
2020
Q1
$5.85M Sell
88,630
-17,336
-16% -$1.22M 1.97% 24
2019
Q4
$7.31M Sell
105,966
-3,509
-3% -$239K 2.05% 23
2019
Q3
$8.1M Sell
109,475
-1,884
-2% -$137K 2.47% 17
2019
Q2
$8.02M Sell
111,359
-6,092
-5% -$432K 2.48% 17
2019
Q1
$8.1M Sell
117,451
-13,606
-10% -$879K 2.63% 13
2018
Q4
$7.86M Sell
131,057
-4,292
-3% -$269K 2.99% 10
2018
Q3
$9.07M Sell
135,349
-1,328
-1% -$88.5K 3% 9
2018
Q2
$8.88M Sell
136,677
-837
-0.6% -$54.8K 3.28% 9
2018
Q1
$9.9M Sell
137,514
-846
-0.6% -$60.9K 3.83% 7
2017
Q4
$10.4M Sell
138,360
-4,126
-3% -$301K 3.91% 7
2017
Q3
$10.4M Sell
142,486
-1,036
-0.7% -$74.7K 4.1% 6
2017
Q2
$10.6M Sell
143,522
-800
-0.6% -$59.4K 4.38% 4
2017
Q1
$10.5M Sell
144,322
-486
-0.3% -$34K 4.49% 4
2016
Q4
$9.41M Sell
144,808
-26
-0% -$1.78K 4.28% 4
2016
Q3
$10.7M Sell
144,834
-1,656
-1% -$122K 4.94% 3
2016
Q2
$10.7M Buy
146,490
+339
+0.2% +$24.1K 4.91% 3
2016
Q1
$10.4M Sell
146,151
-795
-0.5% -$52.9K 4.81% 3
2015
Q4
$9.85M Sell
146,946
-3,161
-2% -$210K 4.76% 3
2015
Q3
$9.46M Buy
150,107
+388
+0.3% +$25.3K 4.73% 3
2015
Q2
$9.73M Sell
149,719
-1,336
-0.9% -$90.6K 4.74% 3
2015
Q1
$10.4M Sell
151,055
-68
-0% -$4.7K 5% 2
2014
Q4
$10.4M Buy
151,123
+238
+0.2% +$16.1K 5.07% 2
2014
Q3
$9.81M Sell
150,885
-1,512
-1% -$99.7K 5% 2
2014
Q2
$10.4M Sell
152,397
-1,937
-1% -$130K 5.31% 2
2014
Q1
$10M Sell
154,334
-2,077
-1% -$131K 5.37% 2
2013
Q4
$10.2M Sell
156,411
-3,213
-2% -$206K 5.49% 1
2013
Q3
$10.5M Sell
159,624
-462
-0.3% -$27.4K 5.89% 1
2013
Q2
$9.13M Buy
+160,086
New +$9.5M 5.84% 1

Other funds holding CL

Dillon & Associates's CL Position: Q1 2026 in Review

Dillon & Associates reduced its Colgate-Palmolive (CL) stake by 7.6% in Q1 2026, selling an estimated $193K and leaving 26,489 shares worth $2.25M. The position accounts for 0.31% of the portfolio, ranked #43.

Dillon & Associates first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.7M in Q3 2016. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Dillon & Associates held 26,489 shares of Colgate-Palmolive worth $2.25M as of Q1 2026.
  • Dillon & Associates sold 2,167 Colgate-Palmolive shares in Q1 2026, an estimated $193K.
  • Colgate-Palmolive made up 0.31% of Dillon & Associates's portfolio in Q1 2026, its #43 holding.
  • Dillon & Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Dillon & Associates's Colgate-Palmolive position peaked at $10.7M in Q3 2016.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Dillon & Associates's 13F filing for Q1 2026, filed 7 May 2026.